Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Estroven expands into weight management; Vitamints offer fresh take on nutrition; N(R) supplement is first product with Niagen; Designer Protein touts Sustained Energy; AssuriTEA Sport fights fatigue; more New Products In Brief.

You may also be interested in...



New Products In Brief

US Organic Group offers organic OTC anti-itch balm; Nordic Natural expands ProEPA line; Clearblue pregnancy test tracks time since ovulation; Nutrition 21 touts Nitrosigine as superior arginine; Culturelle probiotics go chewable; more New Products In Brief.

PBMs’ ‘Perverse Incentives’ Still Limiting Generics Access, AAM Report Reiterates

Generic medicines continue to be intentionally left off formulary tiers in favor of more expensive brand medications, according to a new report from the US Association for Accessible Medicines.

Strong Launches Will Help BMS Win The LOE Battle In 2023 And Beyond

Bristol Myers Squibb brought the last of nine new drugs to market last year – all needed to help it overcome three big losses of exclusivity this decade – so the focus this year is commercial execution. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel